Myungin Pharm Co Ltd
317450
Company Profile
Business description
Myungin Pharm Co Ltd is engaged in the production and sale of psychotropic drugs that act as central nervous system (neurology and psychiatry) medications. The company manufacture and sell prescription drugs, including those for stroke and Parkinson's disease, schizophrenia, and depression.
Contact
361-2 Noha-gil
Paltan-myeon
Gyeonggi-do
Hwaseong-si
KORT: +82 234659622
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,170.82 | 17.77 | -0.22% |
| DAX 40 | 24,137.44 | 306.45 | 1.29% |
| Dow JONES (US) | 46,190.61 | 238.37 | 0.52% |
| FTSE 100 | 9,389.34 | 34.77 | 0.37% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,679.97 | 117.44 | 0.52% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,664.01 | 34.94 | 0.53% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |